An Overview of Myelodysplastic Syndrome
An Overview of Myelodysplastic Syndrome
Sep 22, 2021
targetedonc.com
A 52-Year-Old Woman With HER2-Positive Breast Cancer
A 52-Year-Old Woman With HER2-Positive Breast Cancer
May 22, 2019
targetedonc.com
The Targeted Pulse: Two Breakthrough Therapy Designations in Breast Cancer and NSCLC, FDA Approvals, and More
The Targeted Pulse: Two Breakthrough Therapy Designatio…
Jun 2, 2024
targetedonc.com
FDA's July 2024 Roundup: Breakthroughs and Milestones in Cancer Treatment
FDA's July 2024 Roundup: Breakthroughs and Milestones in …
Aug 2, 2024
targetedonc.com
Findings for the Combination of Anti-TIM-3 and Anti-PD-1 in Melanoma and Lung Cancer
Findings for the Combination of Anti-TIM-3 and Anti-PD-1 in Melan…
Dec 27, 2018
targetedonc.com
Overview of MET Amplification and MET Exon 14 Skipping Mutations in NSCLC
Overview of MET Amplification and MET Exon 14 Skipping Mutations i…
Dec 7, 2021
targetedonc.com
MARIPOSA-2: Amivantamab Lazertinib Chemotherapy in EGFR-Mutated Advanced NSCLC
MARIPOSA-2: Amivantamab Lazertinib Chemotherapy in EGF…
Nov 14, 2023
targetedonc.com
Phase 3 HIMALAYA Trial Shows OS Benefit of Durvalumab in HCC
Jan 18, 2023
targetedonc.com
Overview: A 65-Year-Old Man with Metastatic Colorectal Cancer
Sep 23, 2021
targetedonc.com
Lung-MAP Trial of Pembrolizumab Plus Ramucirumab Improves Over…
Aug 31, 2022
targetedonc.com
Nirogacestat Shows Statistically Significant Improvements in Desm…
Nov 28, 2023
targetedonc.com
Characteristics of the MET Exon 14 Skipping Mutation NSCLC Populat…
Dec 1, 2021
targetedonc.com
3:50
NSABP B-51: Loco-Regional Irradiation in Patients Who Becom…
Dec 15, 2023
targetedonc.com
Addressing Unmet Needs in Renal Cell Carcinoma
Apr 5, 2022
targetedonc.com
Key Updates from ARMANI in Advanced HER2- Gastric/GEJ Can…
Jun 24, 2024
targetedonc.com
A Brief History of Immunotherapy
Aug 21, 2014
targetedonc.com
Treatment After Progression on Osimertinib for EGFR NSCLC
Mar 4, 2020
targetedonc.com
Evaluating Quality of Care for Patients With Medicaid vs Private I…
Oct 5, 2022
targetedonc.com
An Introduction to Front-line Nivolumab/Ipilimumab Therapy fo…
7 months ago
targetedonc.com
Brain Benefits: Targeted Therapy Offers New Weapon Against HER…
Jul 5, 2024
targetedonc.com
Pirtobrutinib as a Game Changer for Patients With CLL
Mar 14, 2024
targetedonc.com
The Role of Luspatercept in the Evolving Treatment Landscape of …
7 months ago
targetedonc.com
Defining Platinum Sensitivity vs Resistance after First-Line Treatm…
Dec 18, 2020
targetedonc.com
Key Takeaways from the OUTBACK Trial of Adjuvant Chemotherapy i…
Jul 23, 2022
targetedonc.com
Options for MRD Testing Affect Patient Treatment Plan in Lung Ca…
7 months ago
targetedonc.com
Elacestrant Targeted Therapy for ER /HER2– Metastatic Breast Cancer: …
Jul 3, 2024
targetedonc.com
Belzutifan Shows Continued Efficacy in Heavily Pretreated Adv…
Nov 4, 2022
targetedonc.com
Case Overview: A 58-Year-Old Woman With Polycythemia Vera
Apr 30, 2019
targetedonc.com
KEYNOTE-756: Pembrolizumab Plus Chemo in Early-Stage ER /HER2- …
Nov 9, 2023
targetedonc.com
Multiple Myeloma Treatment: New Therapies vs Stem Cell Transplant
Apr 3, 2024
targetedonc.com
See more videos
Static thumbnail place holder